FGFR4 is reportedly overexpressed in various cancers, such as breast, prostate, hepatocellular, ovarian, gastric, colorectal, and pancreatic cancer, where it may contribute to tumor progression [20,21,22,23]. This evidence concerns the gene FGFR4 and neoplasm.